Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > Expectations for 2022
View:
Post by PapaGG3 on Jan 02, 2022 11:17am

Expectations for 2022

The year ahead looks bright for cannabis, with all signs pointing to sustained growth over the next several years. In fact,Marijuana Business Dailyreports that legal cannabis sales in the U.S. are expected to surpass $30 billion in 2022. The increase comes after several states passed recreational and medical cannabis initiatives in 2021, increasing access to marijuana.Insider reportsthat 18 states and Washington, D.C. have now legalized recreational cannabis, and 37 states allow medicinal cannabis use. A Gallup Poll published this year found that68% of Americans support marijuana legalization. As popular opinion favors cannabis, businesses will likely be even more incentivized to invest in the industry. The popularity of embracing plant-based medicine for pain relief will likely grow, too. And, in time, smoking a joint or eating an edible may be as socially acceptable as having a glass of wine or cracking open a beer.
Comment by SusanBolland on Jan 02, 2022 11:21am
great points
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities